Carla Bauer
Director - Oncology Search & Evaluation, Business Development & Licensing Merck & Co
Seminars
Wednesday 18th February 2026
Pharma Perspectives Panel Discussion: Successfully Engaging with Large Pharma Companies to Secure Future Partnerships for GBM Therapeutic Development
3:30 pm
- Identifying specific data packages, preclinical models and clinical milestones that will make a GBM asset attractive for a partnership, beyond scientific novelty
- Strategies for pitching, due diligence considerations and building collaborative relationships to effectively engage with big pharma business development teams to secure a deal
- Insights into creative deal terms, IP considerations and defining clear roles and responsibilities to ensure both partners are aligned on the path to clinical and commercial success